MANAGEMENT OF A PATIENT WITH ANKYLOSING SPONDYLITIS TYPE SPONDYLOARTHRITIS AND LATENT TUBERCULOSIS INFECTION
Downloads
become active TB. We reported a case of a 57-year-old man with AS. Patient was planned to be treated with DMARD so that hepatitis and TB screening performed. It was discovered that this patient had LTBI. The prophylactic therapy for TB was given. DMARD therapy started 1 month after TB prophylactic therapy was given. For monitoring the disease progression,
anamnesis, physical, laboratory, and radiology examination performed regularly.
Ai JW, Ruan QL, Liu QH, Zhang WH. 2016. Updates on the risk factors for latent
tuberculosis reactivation and their managements. EmergMicrob Infect.2016:5:h.1-8
Badan Penelitian dan Pengembangan Kesehatan Kementrian RI. 2013. Epidemilogi
Penyakit Reumatik. Epidemiologi Penyakit di Indonesia. Jakarta: Balai Pustaka
Brassard P, Kezouh A, Suissa S. 2006. Antirheumatic Drugs and the Risk of
Tuberculosis. Clin Infect Dis 2006;43:717-722
Braun J, van der Berg R, Baraliakos X, Boehn H, Burgos-Vargas R, Collantes-Estevez E,
et al. 2011. 2010 Update of the ASAS/EULAR recommendations for the management
of ankylosing spondylitis. Ann Rheum Dis 2011;70:896-904
Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, et al. 2015.
Guidance for the management of patients with latent tuberculosis infection requiring
biologic therapy in rheumatology and dermatology clinical practice. Autoimmun
Rev, 2015;14:h.503-9
CDC. 2013. Latent tuberculosis infection: a guide for primary health care providers.
Atlanta: Centers for Disease Control and Prevention
Fitzgerald O. 2013. Psoriatik arthritis. In: Firestein GS, et al. (eds) Kelley's Textbook of
Rheumatology. 9th ed. Philadelphia: Saunders Elsevier, 2013. pp. 1401-1419
Iannone F, Cantini F & Lapadula G. 2014. Diagnosis of latent tuberculosis and
prevention of reactivation in rheumatic patients receiving biologic therapy:
international recommendations. J Rheumatol, 2014;91:h.41-6
Inanc N, Aydin SZ, Karakurt S, Ataqunduz P, Yavuz S et al. 2009. Agreement between
Quantiferon-TB gold test and tuberculin skin test in the identification of latent
tuberculosis infection in patients with rheumatoid arthritis and ankylosing
spondylitis. J Rheumatol;36:12:h.2675-81
Iseman MD. 2011. Mycobacterial infections in era of modern biologic agents. Am J Med
Sci, 341:h.278-80
Kementrian Kesehatan Republik Indonesia. 2014. Pedoman nasional pengendalian
tuberkulosis. Jakarta: Kemenkes RI; 2014
Perhimpunan Reumatologi Indonesia. 2014. Rekomendasi Perhimpunan Reumatologi
Indonesia (IRA) untuk spondiloartropati. Jakarta: Perhimpunan Reumatologi
Indonesia; 2014:h. 2-3
Perhimpunan Reumatologi Indonesia. 2017. Pedoman Penapisan dan Tata Laksana
Infeksi Tuberkulosis Laten pada Pasien Penyakit Reumatik yang Akan Mendapatkan
Terapi DMARD Biologik. Jakarta: Perhimpunan Reumatologi Indonesia; 2017:h.11-
Rudwaleit M, van der Heijde D, Landewe R, Listing J, Akkoc N, Brandt J, Chou CT, et
al. 2011 The Assessment of SpondyloArthritis international Society Classification
kriteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann
Rheum Dis 2011;70:25-31
Smolen JS, Landewe R, Breedveld FC, Buch M, Burnester G, Dougados M. 2013.
EULAR recommendations for the management of rheumatoid arthritis with synthetic
and biological disease-modifying anturheumatic drugs: 2013 update. Ann Rheum
Dis. 2013;0;h.1-18.
van der Heijde D, Ramiro S, Landewe R, Baraliakos X, van den Bosch F, et al.,2017.
update of the ASAS-EULAR management recommendations for axial
spondyloarthtritis. Ann Rheum Dis 2017;76:978-991
van der Linden S, Valkenburg HA, Cats A. 1984. Evaluation of diagnostic criteria for
ankylosing spondylitis: A proposal for modification of the New York kriteria. Arthritis
Rheum 1984;27:361-8
van der Linden SM, van der Heijde D, Maksynowych WP. 2013. Ankylosing spondylitis.
In: Firestein GS et al. (eds) Kelley's Textbook of Rheumatology. 9th ed. Philadelphia:
Saunders Elsevier, 2013. pp. 1366-89
WHO. 2017. Global Tuberculosis Report 2017. In: www.who.int/tb/data
WHO. 2015. Guideline on the management of latent tuberculosis infection. Geneva:
World Health Organization
Wollheim FA. 2013. Enteropathric arthritis. In: Firestein GS, et al. (eds) Kelley's
Textbook of Rheumatology. 9th ed. Philadelphia: Saunders Elsevier, 2013. pp. 1420-
Xu Z, Xu P, Fan W, Yang G, Wang J, Cheng Q, & Yu M. 2017. Risk of infection in
patients with spondyloarthritis and ankylosing spondylitis receiving antitumor
necrosis factor therapy: A meta-analysis of randomized controlled trials. In:
Experimental and Therapeutic Med 14: 3491-3500
Yan Yu DT, McGonagle D, Marzo-Ortega H, van den Bosch F, Leirisalo-Repo M. 2013.
Undifferentiated spondyloarthritis and reactive arthriti. In: Firestein GS, et al. (eds)
Kelley's Textbook of Rheumatology. 9th ed. Philadelphia: Saunders Elsevier, 2013.
pp.1390-1400
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
